BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang R, Lee I, Lee TA, Pickard AS. The societal cost of heroin use disorder in the United States. PLoS One 2017;12:e0177323. [PMID: 28557994 DOI: 10.1371/journal.pone.0177323] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Smart R, Reuter P. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials. Addiction 2022;117:518-31. [PMID: 34105206 DOI: 10.1111/add.15601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 May AC, Davis C, Kirlic N, Stewart JL. Mindfulness-Based Interventions for the Treatment of Aberrant Interoceptive Processing in Substance Use Disorders. Brain Sciences 2022;12:279. [DOI: 10.3390/brainsci12020279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fuller GW, Jones M, Bradshaw CA, Jones J, John A, Snooks H, Watkins A. The Socio-Demographics and Health Service Use of Opioid Overdose Decedents in Wales: A Cross-Sectional Data Linkage Study. Eur Addict Res 2022;:1-5. [PMID: 35172309 DOI: 10.1159/000521614] [Reference Citation Analysis]
4 Davis S, Zhu J. Substance abuse and neurotransmission. Behavioral Pharmacology of Drug Abuse: Current Status 2022. [DOI: 10.1016/bs.apha.2021.10.007] [Reference Citation Analysis]
5 Monk-turner E, Fu H, Yang X. Heroin Use in China and the United States. Handbook of Substance Misuse and Addictions 2022. [DOI: 10.1007/978-3-030-67928-6_93-1] [Reference Citation Analysis]
6 Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden LM, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial. Addict Sci Clin Pract 2021;16:61. [PMID: 34635178 DOI: 10.1186/s13722-021-00268-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rege SV, Woods M, Ross J, Holstege CP. Heroin Exposures Reported to a National Real-time Poison Database. Int J Ment Health Addiction 2021. [DOI: 10.1007/s11469-021-00626-8] [Reference Citation Analysis]
8 Rege SV, Smith M, Borek HA, Holstege CP. Opioid Exposures Reported to U.S. Poison Centers. Subst Use Misuse 2021;56:1169-81. [PMID: 33939935 DOI: 10.1080/10826084.2021.1914101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hyatt JM, Powell K, Bell NK, Bucklen KB, Langleben D. Assessment of Attitudes Towards Medication-Assisted Drug Treatment Options among an Incarcerated Population. Corrections 2021. [DOI: 10.1080/23774657.2021.1884032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Park S, Powell D. Is the rise in illicit opioids affecting labor supply and disability claiming rates? J Health Econ 2021;76:102430. [PMID: 33524644 DOI: 10.1016/j.jhealeco.2021.102430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Robin AM, Hersh AR, John C, Caughey AB. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder. J Matern Fetal Neonatal Med 2021;:1-9. [PMID: 33455473 DOI: 10.1080/14767058.2021.1873266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ballard PJ, Pankratz M, Wagoner KG, Cornacchione Ross J, Rhodes SD, Azagba S, Song EY, Wolfson M. Changing course: supporting a shift to environmental strategies in a state prevention system. Subst Abuse Treat Prev Policy 2021;16:7. [PMID: 33430898 DOI: 10.1186/s13011-020-00341-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kawasaki S, Dunham E, Mills S, Kunkel E, Gonzalo JD. The opioid epidemic: Mobilizing an academic health center to improve outcomes. J Subst Abuse Treat 2021;121:108199. [PMID: 33357608 DOI: 10.1016/j.jsat.2020.108199] [Reference Citation Analysis]
14 Zhao X, Wang L, Maes JH. Training and transfer effects of working memory training in male abstinent long-term heroin users. Addictive Behaviors Reports 2020;12:100310. [DOI: 10.1016/j.abrep.2020.100310] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Seguí HA, Melin K, Quiñones DS, Duconge J. A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder. J Transl Genet Genom 2020;4:263-77. [PMID: 33274315 DOI: 10.20517/jtgg.2020.35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jones M, Bell F, Benger J, Black S, Buykx P, Dixon S, Driscoll T, Evans B, Edwards A, Fuller G, Goodacre S, Hoskins R, Hughes J, John A, Jones J, Moore C, Sampson F, Watkins A, Snooks H. Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study. Pilot Feasibility Stud 2020;6:96. [PMID: 32670598 DOI: 10.1186/s40814-020-00626-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mella-Raipán J, Romero-Parra J, Recabarren-Gajardo G. DARK Classics in Chemical Neuroscience: Heroin and Desomorphine. ACS Chem Neurosci 2020. [PMID: 32568519 DOI: 10.1021/acschemneuro.0c00262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ovalle F, Dembinski D, Yalamanchili S, Minkara A, Stern PJ. Hand and Upper Extremity Infections in Intravenous Drug Users: Epidemiology and Predictors of Outcomes. The Journal of Hand Surgery 2020;45:503-11. [DOI: 10.1016/j.jhsa.2020.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Knudsen HK, Brown R, Jacobson N, Horst J, Kim JS, Collier E, Starr S, Madden LM, Haram E, Molfenter T. Pharmacotherapy, Resource Needs, and Physician Recruitment Practices in Substance Use Disorder Treatment Programs. J Addict Med 2019;13:28-34. [PMID: 30095565 DOI: 10.1097/ADM.0000000000000441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Alambyan V, Pace J, Miller B, Cohen ML, Gokhale S, Singh G, Shun MC, Hammond A, Ramos-Estebanez C. The Emerging Role of Inhaled Heroin in the Opioid Epidemic: A Review. JAMA Neurol 2018;75:1423-34. [PMID: 29987325 DOI: 10.1001/jamaneurol.2018.1693] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
21 Reinert J, Leis R, Paplaskas A, Bakle-carn D. Defining the Correlation Between Heroin Overdose and Length of Hospital Admissions. Journal of Pharmacy Technology 2019;35:243-50. [DOI: 10.1177/8755122519860081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Stafford NP, Kazan TN, Donovan CM, Hart EE, Drugan RC, Charntikov S. Individual Vulnerability to Stress Is Associated With Increased Demand for Intravenous Heroin Self-administration in Rats. Front Behav Neurosci 2019;13:134. [PMID: 31293400 DOI: 10.3389/fnbeh.2019.00134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
23 Crist RC, Clarke TK, Berrettini WH. Pharmacogenetics of Opioid Use Disorder Treatment. CNS Drugs 2018;32:305-20. [PMID: 29623639 DOI: 10.1007/s40263-018-0513-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
24 Gicquelais RE, Foxman B, Coyle J, Eisenberg MC. Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance. Epidemics 2019;27:86-95. [PMID: 30930214 DOI: 10.1016/j.epidem.2019.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
25 Gedeon C, Sandell M, Birkemose I, Kakko J, Rúnarsdóttir V, Simojoki K, Clausen T, Nyberg F, Littlewood R, Alho H. Standards for opioid use disorder care: An assessment of Nordic approaches. Nordisk Alkohol Nark 2019;36:286-98. [PMID: 32934565 DOI: 10.1177/1455072518815322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Locketz GD, Brant JD, Adappa ND, Palmer JN, Goldberg AN, Loftus PA, Chandra RK, Bleier BS, Mueller SK, Orlandi RR, Becker M, Dorminy CA, Becker SD, Blasetti M, Becker DG. Postoperative Opioid Use in Sinonasal Surgery. Otolaryngol Head Neck Surg 2019;160:402-8. [DOI: 10.1177/0194599818803343] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
27 Hofford RS, Russo SJ, Kiraly DD. Neuroimmune mechanisms of psychostimulant and opioid use disorders. Eur J Neurosci 2019;50:2562-73. [PMID: 30179286 DOI: 10.1111/ejn.14143] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
28 Dhanda A, O'connor SS, Mcguire H, Knox E, Ruth E. Patterns of opioid use during initial buprenorphine/naloxone treatment in relation to changes in opioid management laws in Kentucky: Patterns of Opioid Use and the Effects of Policy. Am J Addict 2018;27:560-6. [DOI: 10.1111/ajad.12767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Zhan J, Jordan CJ, Bi GH, He XH, Gardner EL, Wang YL, Xi ZX. Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice. Neuropharmacology 2018;141:11-20. [PMID: 30138692 DOI: 10.1016/j.neuropharm.2018.08.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
30 Imperio CG, McFalls AJ, Hadad N, Blanco-Berdugo L, Masser DR, Colechio EM, Coffey AA, Bixler GV, Stanford DR, Vrana KE, Grigson PS, Freeman WM. Exposure to environmental enrichment attenuates addiction-like behavior and alters molecular effects of heroin self-administration in rats. Neuropharmacology 2018;139:26-40. [PMID: 29964093 DOI: 10.1016/j.neuropharm.2018.06.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
31 Abu Jawdeh EG, Westgate PM, Pant A, Stacy AL, Mamilla D, Gabrani A, Patwardhan A, Bada HS, Giannone P. Prenatal Opioid Exposure and Intermittent Hypoxemia in Preterm Infants: A Retrospective Assessment. Front Pediatr 2017;5:253. [PMID: 29270395 DOI: 10.3389/fped.2017.00253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
32 Faryar KA, Freeman CL, Persaud AK, Furmanek SP, Guinn BE, Mattingly WA, Wiemken TL, Buckner KA, Huecker MR. The Effects of Kentucky's Comprehensive Opioid Legislation on Patients Presenting with Prescription Opioid or Heroin Abuse to One Urban Emergency Department. J Emerg Med 2017;53:805-14. [PMID: 29102093 DOI: 10.1016/j.jemermed.2017.08.066] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
33 Gicquelais RE, Foxman B, Coyle J, Eisenberg MC. Insights into Hepatitis C Transmission in Young Persons who Inject Drugs: Results From a Dynamic Modeling Approach Informed by State-Level Public Health Surveillance Data.. [DOI: 10.1101/193185] [Reference Citation Analysis]
34 Heroin use disorder "tremendous cost to society" in the US. PharmacoEcon Outcomes News 2017;781:21-21. [DOI: 10.1007/s40274-017-4113-6] [Reference Citation Analysis]
35 Debenedetto R, Luttrell S. Opioid Overdose. PharmacotherapyFirst: A Multimedia Learning Resource 2017. [DOI: 10.21019/pharmacotherapyfirst.opioid-overdose_overview] [Reference Citation Analysis]
36 Debenedetto R, Luttrell S. Opioid Use and Misuse. PharmacotherapyFirst: A Multimedia Learning Resource 2017. [DOI: 10.21019/pharmacotherapyfirst.opioid-use_overview] [Reference Citation Analysis]